Anastrozole and CJC-1295 (without DAC) Interaction

Synergistic
Mechanism-based 60% confidence

Anastrozole and CJC-1295 (without DAC) have a synergistic interaction with 60% confidence. CJC-1295 (without DAC) helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. Both compounds affect the pituitary, so monitoring these systems is recommended.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low
GI Tract
low

Shared Safety Flags

2x 2 estrogenic compounds (Anastrozole, CJC-1295 (without DAC)). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 compounds share the teratogenic safety flag (Anastrozole, CJC-1295 (without DAC)). Monitor accordingly.

Frequently Asked Questions

Can I take Anastrozole with CJC-1295 (without DAC)?

Yes, Anastrozole and CJC-1295 (without DAC) can generally be taken together. CJC-1295 (without DAC) helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is Anastrozole and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: estrogenic, teratogenic. Monitor accordingly.

What are the interactions between Anastrozole and CJC-1295 (without DAC)?

CJC-1295 (without DAC) helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anastrozole and CJC-1295 (without DAC)?

Anastrozole has a half-life of ~40-50 hours and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anastrozole vs CJC-1295 (without DAC)

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.